
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-4 September 2025
September 9, 2025
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-4 September 2025
EMA’s safety committee (PRAC) has started a review of medicines containing levamisole, authorised in four…